Longevity News

Nona Biosciences Enters Research Collaboration with the Medical University of Vienna to Advance Fully Human Antibody Development for Infectious Diseases

Source: PR Newswire • Published: 23 Jul 2026, 00:55

Nona Biosciences Enters Research Collaboration with the Medical University of Vienna to Advance Fully Human Antibody Development for Infectious Diseases

A biomedical collaboration story about a university gaining access to a transgenic mouse platform for generating fully human antibodies, useful for researchers interested in infectious disease discovery and translational antibody tools.

Key Takeaways
  • Collaboration enables the inter-university Ignaz Semmelweis Institute – directed by Prof
  • H2L2 Harbour Mice ® platform and all associated intellectual property rights remain vested in Nona Biosciences
  • "We are delighted to partner with the Medical University of Vienna
Read Original Source